Medication info
Ciprofloxacin Tablets 250 mg (Ciprofloxacin Hydrochloride Hemihydrate)

Ciprofloxacin Tablets 250 mg (Ciprofloxacin Hydrochloride Hemihydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White to pale yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200404700 · Notified 2004.07.09 · Insurance code 671700650

Summary

Main use
Treatment of genitourinary, respiratory, eye, ear, nose and throat, abdominal, skin, and osteoarticular infections
Who takes it
Adults
Adult dose
○ Usual adult dose: Take 250 ~ 500 mg of ciprofloxacin per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance may be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment, but the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of genitourinary, respiratory, eye, ear, nose and throat, abdominal, skin, and osteoarticular infections

  • Respiratory infections excluding acute bronchitis
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
  • complicated urinary tract infections
  • gonococcal cervicitis
View approved original text

This medication is effective against various bacteria and is used for respiratory infections excluding acute bronchitis, as well as community-acquired pneumonia. Additionally, it is applicable for throat and ear infections including pharyngitis, tonsillitis, laryngitis, otitis externa, and chronic cholesteatomatous otitis media (except for chronic otitis media prior to surgery). It is also effective for urinary tract infections such as bacterial prostatitis, acute uncomplicated cystitis, acute pyelonephritis, and complicated urinary tract infections. Furthermore, it can be used for gonococcal cervicitis and gonococcal urethritis, gastrointestinal infections, biliary tract infections, skin and soft tissue infections, and wound treatment. This drug is also used for bone and joint infections, gynecological infections (excluding vaginal infections), peritonitis, fistula infections, sebaceous cysts, otitis media cholesteatomatosa, acute bacterial rhinosinusitis, chronic bronchitis, and acute bacteremia exacerbation of chronic obstructive pulmonary disease, as well as acute cystitis and otitis media. However, as a fluoroquinolone, it may have serious adverse reactions and is recommended for use only when no other treatment options are available for specific conditions.

How to take

Adult dose

○ Usual adult dose: Take 250 ~ 500 mg of ciprofloxacin per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance may be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment, but the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication may cause serious side effects such as tendonitis or tendon rupture, peripheral neuropathy, and central nervous system effects. If such symptoms occur, discontinue use immediately and consult a healthcare professional. Patients with myasthenia gravis are advised not to take this medication as it may worsen symptoms. This drug should be used restrictedly for specific infections and only when no alternative treatment is available. Caution is especially needed for elderly patients, those with decreased kidney function, or those with central nervous system disorders. Pregnant or breastfeeding women, children under 18 years of age, patients with epilepsy, and those with hypersensitivity to this drug should not take it. This medication may interact with several other drugs, so be sure to inform your healthcare provider of any other medications being taken. During treatment, care should be taken to avoid excessive exposure to sunlight or artificial UV light, and if a rash or itching occurs, the medication should be discontinued immediately. This drug may cause changes in blood sugar levels, so diabetic patients should monitor their blood sugar frequently. Use caution while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, kidney function may be compromised, and immediate emergency treatment is required. This drug has not been established as safe for use in children or growing adolescents.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin reduction, hematocrit reduction, agranulocytosis, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, appetite decrease, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, hyperactivity, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, loss of taste, tremors, convulsions, dizziness, mental confusion, seizures, drowsiness, migraines, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual disturbances, dyschromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with blood in stool, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, pruritus, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, exacerbation of myasthenia gravis, renal impairment, elevated BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vulvovaginal candidiasis, undetermined pain, discomfort, fever, weakness, edema, sweating, gait disturbance, maculopapular rash, purpuric rash, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid air exposure and kept at room temperature between 1°C and 30°C. Proper storage helps maintain the drug's effectiveness.

Appearance and packaging

Appearance

White to pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.